Actively Recruiting
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Led by Qilu Hospital of Shandong University · Updated on 2024-11-21
162
Participants Needed
3
Research Sites
137 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
CONDITIONS
Official Title
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Repeated chest pain attacks with typical exertional or resting angina pectoris attacks
- Coronary arteries normal or stenosis less than 20%
- Ischemic depression in ST segment during rest or exercise
- Blood flow reserve of anterior descending coronary artery less than 2.0
- Agreement by subjects or their guardians to participate in the study
You will not qualify if you...
- Previous myocardial infarction, PCI, or CABG treatment
- History of heart failure
- Severe arrhythmia
- Refractory hypertension or hypertension with left ventricular wall thickness greater than 12 mm
- Familial hypercholesterolemia
- Takayasu arteritis, Kawasaki disease, or coronary artery malformation
- Pregnancy, nursing, or intention to give birth within one year
- Hepatic or renal dysfunction
- Allergy to contrast agents or traditional Chinese medicines
- Participation in other drug clinical research within 3 months before selection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China, 250012
Active, Not Recruiting
2
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012
Actively Recruiting
3
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China, 250031
Actively Recruiting
Research Team
P
Panpan Hao, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here